Latest News

04

August 2020

iX Biopharma Ltd is pleased to announce the allowance of WaferiX™ Patent by United States Patent and Trademark Office...

Read On

29

July 2020

iX Biopharma Ltd has announced a proposed placement of 44,491,299 new ordinary shares...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com